Who are HEPATITIS B SURFACE ANTIGEN's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Comirnaty, Prevnar 20, rVSV∆G-ZEBOV-GP, Hib conjugate vaccine, Hepatitis B Vaccine, Hepatitis A (control).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hepatitis-b-surface-antigen.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

HEPATITIS B SURFACE ANTIGEN — Competitive Intelligence Brief

HEPATITIS B SURFACE ANTIGEN (HEPATITIS B SURFACE ANTIGEN) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Immunology / Infectious Disease.

marketed vaccine Hepatitis B surface antigen (HBsAg) Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

HEPATITIS B SURFACE ANTIGEN (HEPATITIS B SURFACE ANTIGEN) — Central Hospital, Nancy, France. Hepatitis B surface antigen (HBsAg) is a viral protein used as an immunogen to stimulate the body's immune system to produce protective antibodies against hepatitis B virus infection.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
HEPATITIS B SURFACE ANTIGEN TARGET	HEPATITIS B SURFACE ANTIGEN	Central Hospital, Nancy, France	marketed	vaccine	Hepatitis B surface antigen (HBsAg)
Comirnaty	BNT162b2 (tozinameran)	Pfizer Inc.	marketed	vaccine	SARS-CoV-2 virus	2021-08-23
Prevnar 20	pneumococcal 20-valent conjugate vaccine (PCV20)	Pfizer Inc.	marketed	Pneumococcal conjugate vaccine	Streptococcus pneumoniae capsular polysaccharides (20 serotypes)	2021-06-08
rVSV∆G-ZEBOV-GP	rVSV∆G-ZEBOV-GP	University of Birmingham	marketed	Live attenuated viral vector vaccine	Zaire ebolavirus glycoprotein (EBOV-GP)
Hib conjugate vaccine	Hib conjugate vaccine	Public Health England	marketed	Conjugate vaccine	Haemophilus influenzae type b polysaccharide capsule
Hepatitis B Vaccine	Hepatitis B Vaccine	Murdoch Childrens Research Institute	marketed	vaccine	Hepatitis B surface antigen (HBsAg)
Hepatitis A (control)	Hepatitis A (control)	International Vaccine Institute	marketed	inactivated viral vaccine	Hepatitis A virus surface antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2033-06-01 — Prevnar 20 · US 8,895,024 · Composition of matter · US
2035-06-01 — Prevnar 20 · US 10,279,033 · Method of use · US

Sponsor landscape (vaccine class)

Pfizer · 20 drugs in this class
Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
GlaxoSmithKline · 12 drugs in this class
Merck Sharp & Dohme LLC · 12 drugs in this class
Centers for Disease Control and Prevention · 9 drugs in this class
Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
Beijing Center for Disease Control and Prevention · 6 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
Sinovac Biotech Co., Ltd · 4 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). HEPATITIS B SURFACE ANTIGEN — Competitive Intelligence Brief. https://druglandscape.com/ci/hepatitis-b-surface-antigen. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab